Xtandi (enzalutamide capsules and tablets - Astellas/Pfizer) — Cigna
Prostate Cancer – Castration-Resistant (Metastatic or Non-Metastatic)
Initial criteria
- Patient age ≥ 18 years; AND
- Patient meets ONE of the following:
- • The medication is used concurrently with a gonadotropin-releasing hormone (GnRH) analog; OR
- • Patient has had a bilateral orchiectomy.
Approval duration
1 year